When a woman first becomes pregnant, the amount of information given to her about prenatal care may be overwhelming. Throughout this page, our birth injury team will explain the prenatal tests (also known as antenatal tests) that physicians perform to ensure the health and proper development of a newborn baby. The main goal of these tests is to identify high-risk conditions so that harm can be prevented. Injury to a baby’s brain that occurs before, during, or near the time of delivery can cause permanent disabilities such as hypoxic-ischemic encephalopahty (HIE), cerebral palsy (CP), and periventricular leukomalacia (PVL).
Prenatal Testing, Oxygen Deprivation, HIE, and Infant Brain Damage
Prenatal testing has been part of obstetrical practice since the 1970s. Physicians use a number of prenatal assessments to identify fetal risks and complications, allowing them to intervene if necessary. Physicians pay close attention to two abnormal findings in particular: oxygen deprivation (hypoxia) and acidosis (acidity of the baby’s blood due to oxygen deprivation). These findings are the final pathway to infant brain damage, and therefore require careful surveillance. If a baby is oxygen-deprived, prenatal tests may show the following:
- Decreased fetal movement
- Changes in blood flow
- Slow or abnormal fetal heart rate
- Decreased amniotic fluid
When a baby is hypoxic, receptors in the brain send signals through the body that slow fetal heart rate. During antenatal testing, this slowed heart rate may appear as a late deceleration during a nonstress test. A late deceleration is a decrease in the baby’s heart rate below baseline that occurs at the end of the mother’s contraction.
When the baby receives lower-than-normal levels of oxygen in the womb, the baby’s movement will likely decrease in an attempt to conserve oxygen and energy. When the baby’s movement decreases, it may signify ongoing oxygen deprivation, which can lead to brain injury.
When a fetus is oxygen-deprived, the baby’s body will usually direct blood flow towards the most important organs, like the heart and brain, and away from the kidneys, which produce urine. This means the kidneys produce less urine, which results in decreased amniotic fluid levels over time, because amniotic fluid is primarily composed of the baby’s urine. The term “oligohydramnios” refers to abnormally low amniotic fluid.
Prenatal Tests Used to Detect Fetal Oxygen Deprivation and Hypoxic-Ischemic Encephalopathy (HIE)
When a baby starts to show signs of oxygen deprivation, it is known as fetal distress. Prenatal tests that detect the major indications of fetal distress are listed below.
Prenatal Testing: Nonstress Test (NST)
The nonstress test (NST) can be performed as early as the beginning of the third trimester and as late in the pregnancy as needed. It is most frequently performed between weeks 38 and 42 of the pregnancy, but many times started at 28 to 30 weeks depending on risk factors.
The nonstress test is a simple test performed to ensure that unborn babies’ hearts react appropriately to different forms of movement and stimulation. In babies, an acceleration is defined as an increase in heart rate for at least 15 seconds, with an increase of at least 15 beats/minute. If the baby’s oxygen supply is adequate, heart rate accelerations will occur, resulting in a reactive test. When these tests are reactive, they show the presence of normal fetal autonomic function, and the absence of acidosis or neurologic depression.
Sometimes when babies are not receiving sufficient oxygen from the placenta, their heart rates will not accelerate in response to an NST, resulting in a nonreactive test, which may require intervention.
Nonstress tests are also performed if a pregnancy has extended past its due date, as well as during high-risk pregnancies. Reasons for a nonstress test include the following:
- Preeclampsia or maternal high blood pressure
- Gestational diabetes or diabetes treated with medication
- Maternal obesity
- Other maternal medical conditions that might affect the pregnancy
- Intrauterine growth restriction (the baby is not growing properly)
- The baby is less active than normal
- Oligohydramnios (too little amniotic fluid) or polyhydramnios (too much amniotic fluid)
- The mother has had a procedure such as an external cephalic version (which turns a baby from the breech position to the proper birthing position) or a third-trimester amniocentesis (to determine if the baby’s lungs are mature enough for birth, or to check for a uterine infection such as chorioamnionitis)
- The mother has previously lost a baby during the second half of pregnancy. When this is the case, NST testing may begin as early as 28 weeks.
- The baby has been diagnosed with an abnormality or birth defect and requires more frequent monitoring
- The pregnancy is post-term and post-dates
Prenatal Testing: Contraction Stress Test (CST)
A contraction stress test (CST) is performed prior to labor and delivery, to predict how a baby will tolerate labor. CSTs are typically performed at 34 weeks of gestation or later, to ensure that the unborn baby will remain healthy when fetal oxygen levels drop during contractions in labor. A CST is performed to make sure the baby and placenta are healthy and that the baby will receive adequate amounts of oxygen from the placenta during the labor and delivery process.
During a CST, the mother lies on her left side with two devices attached to her abdomen – one monitors the baby’s heartbeat and the other records the mother’s contractions. These are graphed next to each other for the physicians to interpret. If the mother doesn’t have contractions for the first 15 minutes of the test, she may be given Pitocin to induce contractions.
The results of a CST are based on the fetus’ response to oxygen-limiting conditions present during contractions. During a contraction, oxygen stops flowing to the placenta and baby. When the placenta is healthy, it has extra stores of oxygen-rich blood ready for the baby during or after a contraction. If the placenta isn’t functioning properly, the baby may not receive enough oxygen, and their heartbeat will slow down after a contraction in what is referred to as a late deceleration.
The CST is like the NST except the fetal heart rate is evaluated in response to contractions as well as accelerations. The CST is not used very often anymore because it is riskier and more expensive than other tests. Administration of Pitocin is risky because there is no way to predict how it will affect each individual mother and baby; it can lead to uterine tachysystole and other complications. Labor induction drugs such as Pitocin are contraindicated in a number of conditions, such as placenta previa.
Prenatal Testing: Amniotic Fluid Volume (AFV)
Amniotic fluid volume (AFV) is dangerous for the baby if it is too low (oligohydramnios) or too high (polyhydramnios). Amniotic fluid is the protective, sterile fluid that surrounds the fetus in the womb. Abnormalities in AFV are associated with many different pregnancy complications, including premature rupture of the membranes (PROM), preterm birth, abnormal fetal presentation, placental abruption, cord compression, intrauterine growth restriction, and adverse perinatal outcomes, such as hypoxic-ischemic encephalopathy (HIE), which can cause cerebral palsy, periventricular leukomalacia, and intellectual and developmental disabilities (I/DD).
An ultrasound can obtain a measurement called the amniotic fluid index, or AFI. AFI is calculated by measuring the depth of the amniotic fluid in four sections of the womb and adding them together. Near term, an AFI of 9-18 centimeters is considered normal, 5-8 is considered borderline, and 5 or below is considered abnormal. A sudden decrease in amniotic fluid or a significant decrease over a short period of time is considered abnormal even if the AFI is above 5.
At 20-35 weeks of gestation, the AFI in a healthy pregnancy is approximately 14 cm. At weeks 34-36, the amniotic fluid starts to decrease in preparation for birth.
An alternative to the AFI is to determine the maximum pool, which is when the single deepest vertical pocket of amniotic fluid is identified by ultrasound and measured. This is part of the biophysical profile (BPP), which we’ll discuss in the next section.
Amniotic fluid normally increases steadily to about one liter by 34-36 weeks, and then decreases thereafter; most studies report a decrease of about 25% per week. The rate of decline may be as high as 150 milliliters per week at 38-43 weeks. In some cases of oligohydramnios, the volume may be reduced to only a few mL.
Polyhydramnios typically is defined as having around 2,000 mL of amniotic fluid, > 8cm maximum pool, or an AFI greater than or equal to 24 cm. It can be caused by the baby producing too much urine, decreased fetal swallowing, and increased water transfer across the placenta to the baby.
If AFV is abnormal, the baby may need to be delivered early, especially if the cause is unknown. Factors used to determine if a baby should be delivered early include whether other factors indicate the baby is in distress, such as an abnormal or nonreassuring heart rate, or whether the baby’s lungs are mature.
Prenatal Testing: Biophysical Profile (BPP)
The biophysical profile (BPP) predicts the presence or absence of fetal asphyxia (severe hypoxia) as well as the risk of death during the antenatal period (the short period after birth). The BPP can be performed as early as the beginning of the third trimester and is done using an ultrasound over 30 minutes. When BPP results identify a compromised baby, the physician must take steps before progressive acidosis causes death or permanent brain damage in the baby. This may potentially include delivery by emergency C-section. The tests included when obtaining the BPP are:
- A nonstress test (NST)
- Measurement of the amniotic fluid index/volume (AFI/AFV) using ultrasound
- Observation of fetal breathing movements
- Observation of gross body movements
- Observation of tone (reflex and extension movements)
During the BPP, each test parameter has points assigned to it, which when added together, create a score to assess indicators of ongoing or sudden onset hypoxia. Sudden onset (acute) hypoxia is reflected in the NST, breathing, and body movement portions of the BPP, while chronic (ongoing) hypoxia is reflected in the AFI/AFV portion.
The modified BPP (mBPP) is comprised of a nonstress test (a measure of acute oxygenation) and an AFI/AFV (as a measure of longer-term oxygenation).
Prenatal Testing: Doppler Velocimetry
Doppler velocimetry is a prenatal test that gives physicians information about uteroplacental blood flow and the baby’s responses to physiological challenges. It can be performed at the beginning of the third trimester. When blood vessels in the placenta are developing abnormally (as in preeclampsia, hypertension, or sickle cell anemia), there are progressive changes in:
- Placental blood flow
- Fetal blood flow
- Fetal blood pressure
- Fetal heart rate
There are several kinds of prenatal Doppler tests. Each provides different information about the growing baby:
- Umbilical Artery Doppler: Alerts physicians about possible uteroplacental insufficiency that could lead to intrauterine growth restriction (IUGR).
- Middle Cerebral Artery Doppler: Used to monitor and report on fetal anemia; can also provide information about IUGR.
- Venous Doppler: Can assess compromised blood supply in the liver, blood flow through the cardiac cycle, and the presence or absence of cardiac instability.
Doppler measurements are very specific and show blood flow in different vessels. They can even pinpoint blood flow in the maternal component of the placenta. Any abnormal Doppler finding needs very close monitoring and immediate consideration regarding when to deliver.
Medical Malpractice and Prenatal Testing Errors
All medical personnel must follow standards of care in prenatal testing. Regular tests are required, and if the pregnancy is high-risk or the mother has signs of a pregnancy complication, appropriate prenatal testing must take place. When prenatal testing reveals health problems with the mother or baby, medical professionals must intervene.
Medical professionals must constantly be on the lookout for fetal distress. When fetal distress is present, medical personnel must act promptly and treat the condition causing it, since fetal distress almost always is an indication that the baby is not receiving enough oxygen. Often, delivery by emergency C-section is the best intervention when a baby is in distress. It is negligence if physicians fail to perform appropriate prenatal tests or dismiss signs of fetal distress. If this negligence leads to harm, it constitutes medical malpractice.
Trusted Legal Help for Birth Injuries
If your child was permanently harmed as the result of prenatal testing errors, you could be eligible for compensation from a medical malpractice case. The attorneys at Reiter & Walsh ABC Law Centers have helped families of children with birth injuries such as hypoxic-ischemic encephalopathy, cerebral palsy, and periventricular leukomalacia secure the resources necessary to pay for long-term care and support.
Contact our award-winning attorneys today for a free consultation. We will review the medical records and determine if needed prenatal tests were not performed, your baby’s fetal distress was unappreciated or mismanaged, or any other act of negligence occurred. If your child was injured due to malpractice, we will fight to obtain the compensation they deserve for medical care, therapy, and a secure future. Our firm has numerous multimillion dollar verdicts and settlements that attest to our success, and you pay nothing unless we win your case.
Free Case Review | Available 24/7 | No Fee Until We Win
Call our toll-free phone line at 888-419-2229
Press the Live Chat button on your browser
Complete Our Online Contact Form
- Hypoxic-Ischemic Encephalopathy (HIE)
- Fetal Distress FAQs
- High-Risk Pregnancy
- Choosing and Obstetrician
- Birth Injury Glossary
- Verdicts and Settlements
- About Reiter & Walsh, P.C.
Video: What to Expect During Prenatal Care Appointments
In this video, nurse Andrea Shea discusses what to expect during a prenatal appointment, as well as the proper management of a high-risk pregnancy.